Olanzapine depot formulation in rat: a step forward in modelling antipsychotic-induced metabolic adverse effects
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Olanzapine depot formulation in rat: a step forward in modelling antipsychotic-induced metabolic adverse effects
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Volume 17, Issue 01, Pages 91-104
Publisher
Oxford University Press (OUP)
Online
2013-08-07
DOI
10.1017/s1461145713000862
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BMP8B Increases Brown Adipose Tissue Thermogenesis through Both Central and Peripheral Actions
- (2012) Andrew J. Whittle et al. CELL
- Nicotine Induces Negative Energy Balance Through Hypothalamic AMP-Activated Protein Kinase
- (2012) P. B. Martinez de Morentin et al. DIABETES
- Antipsychotic-induced increase in lipid biosynthesis: activation through inhibition?
- (2012) Silje Skrede et al. JOURNAL OF LIPID RESEARCH
- Atypical antipsychotics alter cholesterol and fatty acid metabolism in vitro
- (2012) Alberto Canfrán-Duque et al. JOURNAL OF LIPID RESEARCH
- Hypothalamic mTOR pathway mediates thyroid hormone-induced hyperphagia in hyperthyroidism
- (2012) Luis Varela et al. JOURNAL OF PATHOLOGY
- Chronic olanzapine administration in rats: Effect of route of administration on weight, food intake and body composition
- (2012) Steve Mann et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- A Role for Hypothalamic AMP-Activated Protein Kinase in the Mediation of Hyperphagia and Weight Gain Induced by Chronic Treatment with Olanzapine in Female Rats
- (2011) Ei Sejima et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats
- (2011) Silje Skrede et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Chronic treatment with olanzapine via a novel infusion pump induces adiposity in male rats
- (2011) Miwako Shobo et al. LIFE SCIENCES
- Modeling chronic olanzapine exposure using osmotic minipumps: Pharmacological limitations
- (2011) Gary Remington et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat
- (2011) Goran Jassim et al. PSYCHOPHARMACOLOGY
- Atypical antipsychotic medications increase postprandial triglyceride and glucose levels in male rats: Relationship with stearoyl-CoA desaturase activity
- (2011) Robert K. McNamara et al. SCHIZOPHRENIA RESEARCH
- Central Nervous System Delivery of the Antipsychotic Olanzapine Induces Hepatic Insulin Resistance
- (2010) P. J. F. Martins et al. DIABETES
- Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance
- (2010) Miguel López et al. NATURE MEDICINE
- Potential mechanisms of atypical antipsychotic-induced metabolic derangement: Clues for understanding obesity and novel drug design
- (2010) Roberto Coccurello et al. PHARMACOLOGY & THERAPEUTICS
- Preclinical models of antipsychotic drug-induced metabolic side effects
- (2010) Heidi N. Boyda et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Olanzapine Long-Acting Injection: A 24-Week, Randomized, Double-Blind Trial of Maintenance Treatment in Patients With Schizophrenia
- (2009) John M. Kane et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effects of the antipsychotic drug haloperidol on the somastostatinergic system in SH-SY5Y neuroblastoma cells
- (2009) Jana Sánchez-Wandelmer et al. JOURNAL OF NEUROCHEMISTRY
- Antipsychotic drugs upregulate lipogenic gene expression by disrupting intracellular trafficking of lipoprotein-derived cholesterol
- (2009) I Kristiana et al. PHARMACOGENOMICS JOURNAL
- Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms
- (2009) Gavin P Reynolds et al. PHARMACOLOGY & THERAPEUTICS
- Hypothalamic Fatty Acid Metabolism Mediates the Orexigenic Action of Ghrelin
- (2008) Miguel López et al. Cell Metabolism
- Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
- (2008) J. McGrath et al. EPIDEMIOLOGIC REVIEWS
- Olanzapine-induced weight gain: Chronic infusion using osmotic minipumps does not result in stable plasma levels due to degradation of olanzapine in solution
- (2008) Esther M. van der Zwaal et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Neuroleptics and animal models: feasibility of oral treatment monitored by plasma levels and receptor occupancy assays
- (2008) Emma Perez-Costas et al. JOURNAL OF NEURAL TRANSMISSION
- Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver
- (2008) Johan Fernø et al. PSYCHOPHARMACOLOGY
- Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine
- (2008) Nima Davoodi et al. PSYCHOPHARMACOLOGY
- Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study
- (2008) Gail L. Daumit et al. SCHIZOPHRENIA RESEARCH
- AMPK: a metabolic gauge regulating whole-body energy homeostasis
- (2008) Ricardo Lage et al. TRENDS IN MOLECULAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started